Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) EBT (2018 - 2025)

AVITA Medical's EBT history spans 8 years, with the latest figure at -$11.6 million for Q4 2025.

  • For Q4 2025, EBT fell 123.18% year-over-year to -$11.6 million; the TTM value through Dec 2025 reached -$48.6 million, down 373569.23%, while the annual FY2025 figure was -$48.6 million, 373561.54% down from the prior year.
  • EBT reached -$11.6 million in Q4 2025 per RCEL's latest filing, up from -$13.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $50.2 million in Q4 2024 to a low of -$18.6 million in Q1 2024.
  • Average EBT over 5 years is -$4.3 million, with a median of -$9.2 million recorded in 2023.
  • Peak YoY movement for EBT: skyrocketed 788.84% in 2023, then crashed 123.18% in 2025.
  • A 5-year view of EBT shows it stood at -$5.9 million in 2021, then grew by 8.04% to -$5.5 million in 2022, then soared by 788.84% to $37.6 million in 2023, then skyrocketed by 33.4% to $50.2 million in 2024, then plummeted by 123.18% to -$11.6 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's EBT are -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025).